Joseph Monahan
Hoofd Techniek/Wetenschap/O&O bij ACLARIS THERAPEUTICS, INC.
Vermogen: 222 501 $ op 30-04-2024
Actieve functies van Joseph Monahan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Directeur/Bestuurslid | 01-01-2010 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2010 | - | |
| Oprichter | 01-01-2010 | - |
Loopbaan van Joseph Monahan
Eerdere bekende functies van Joseph Monahan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Opleiding van Joseph Monahan
| State University of New York at Buffalo | Undergraduate Degree |
| University of South Carolina | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Beurs
- Insiders
- Joseph Monahan
- Ervaring
